Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward precision adjuvants: optimizing science and safety
Etsuro Nanishi, David J. Dowling, Ofer Levy
Current Opinion in Pediatrics (2020) Vol. 32, Iss. 1, pp. 125-138
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Emerging concepts in the science of vaccine adjuvants
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 454-475
Open Access | Times Cited: 960
The Innate Immune Response toMycobacterium tuberculosisInfection
Mariëtta M. Ravesloot-Chávez, Erik Van Dis, Sarah A. Stanley
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 611-637
Closed Access | Times Cited: 130
The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Transforming vaccinology
Rino Rappuoli, Galit Alter, Bali Pulendran
Cell (2024) Vol. 187, Iss. 19, pp. 5171-5194
Closed Access | Times Cited: 16
“World in motion” – emulsion adjuvants rising to meet the pandemic challenges
Derek T. O’Hagan, Robbert van der Most, Rushit N. Lodaya, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 68
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models
Jinpeng Su, Livia Brunner, Edanur Ateş Öz, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 4, pp. 717-730
Open Access | Times Cited: 32
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines
Brankica Filipić, Ivana Pantelić, Ines Nikolić, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1172-1172
Open Access | Times Cited: 30
Advances and challenges in cancer immunoprevention and immune interception
Sasha E. Stanton, Philip E. Castle, Olivera J. Finn, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e007815-e007815
Open Access | Times Cited: 9
BCG as a Case Study for Precision Vaccine Development: Lessons From Vaccine Heterogeneity, Trained Immunity, and Immune Ontogeny
Asimenia Angelidou, Joann Diray‐Arce, Maria Giulia Conti, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 68
Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study
Andrew Wiese, Marie R. Griffin, William Schaffner, et al.
Clinical Infectious Diseases (2018) Vol. 68, Iss. 11, pp. 1862-1869
Open Access | Times Cited: 59
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?
Luis M. de la Maza, Toni Darville, Sukumar Pal
Expert Review of Vaccines (2021) Vol. 20, Iss. 4, pp. 421-435
Open Access | Times Cited: 49
Modeling human immune responses to vaccination in vitro
Elena Morrocchi, Simon D. van Haren, Paolo Palma, et al.
Trends in Immunology (2023) Vol. 45, Iss. 1, pp. 32-47
Closed Access | Times Cited: 16
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Polyphosphazene immunoadjuvants: Historical perspective and recent advances
Alexander K. Andrianov, Róbert Langer
Journal of Controlled Release (2020) Vol. 329, pp. 299-315
Open Access | Times Cited: 42
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Tengchuan Jin
Expert Review of Vaccines (2021) Vol. 21, Iss. 1, pp. 69-81
Open Access | Times Cited: 38
The impact of immuno-aging on SARS-CoV-2 vaccine development
Jennifer Connors, Matthew R. Bell, Jennifer Marcy, et al.
GeroScience (2021) Vol. 43, Iss. 1, pp. 31-51
Open Access | Times Cited: 36
Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens
Sudeep Kumar, Karsten R. O. Hazlett, Guangchun Bai
Vaccine (2025) Vol. 48, pp. 126729-126729
Closed Access
Exploring the possible use of saponin adjuvants in COVID-19 vaccine
Rinku Sharma, Arivukarasu Palanisamy, Kuldeep Dhama, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2944-2953
Open Access | Times Cited: 35
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Emerging adjuvants for intradermal vaccination
Xinyuan Chen
International Journal of Pharmaceutics (2022) Vol. 632, pp. 122559-122559
Open Access | Times Cited: 19
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
Timothy R. O’Meara, Etsuro Nanishi, Marisa E. McGrath, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 5, pp. 1107-1120.e6
Open Access | Times Cited: 11
The scientific journey of a novel adjuvant (AS37) from bench to bedside
Ugo D’Oro, Derek T. O’Hagan
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
A synthetic cyclic peptide for promoting antigen presentation and immune activation
Jiahui Zhang, Harrison Y. R. Madge, Asmaa Mahmoud, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Co‐Delivery of Multiple Toll‐Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy
A. Gonzaga Ramírez, Jenny E. Hernandez‐Davies, Aarti Jain, et al.
Advanced Healthcare Materials (2025)
Open Access
Page 1 - Next Page

Scroll to top